Please assess the completion status of the following clinical trial:

Trial Title: Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* renal transplant recipient at least 3 months post transplant~* hypercalcemia~* hyperparathyroidism~Exclusion Criteria:~* allergic to cinacalcet, tetracycline.~* pregnancy~* on medication that utilize same liver system as cinacalcet Hcl

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cinacalcet HCl (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).